Skip to content

The incidence of rigid bronchoscopy complications in children with foreign body aspiration

Comparison of the incidence of rigid bronchoscopy complications with three anesthesia methods of spontaneous ventilation, controlled ventilation using Atracurium and controlled ventilation using Rocuronium in children with foreign body aspiration

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230506058100N1
Enrollment
63
Registered
2023-06-14
Start date
2023-04-30
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foreign body aspiration. Foreign body in respiratory tract, part unspecified

Interventions

Intervention 1: Group P or Propofol : After induction of inhalation anesthesia with Sevoflurane, Propofol infusion is started at a dose of 80-100 mcg/kg/min, and the relaxant drug will not be injecte

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: Parents' consent to participate in the study after bronchoscopy Age range 1 to 6 years Children with foreign body aspiration , if the foreign body is not in the upper part of the main airway and in the larynx or hypopharynx They should be in ASA class 1 and 2

Exclusion criteria

Exclusion criteria: Emergency cases Children with asthma and irritable airways Airway anomaly Drug allergy to any of the drugs used Neurological disorders and seizures kidney disease Cardiovascular disease Neuromuscular disorder Metabolic disorder

Design outcomes

Primary

MeasureTime frame
Laryngospasm. Timepoint: beginning of bronchoscopy to end of anesthesia and the patient waking up. Method of measurement: Decreased oxygen saturation following epiglottis closure.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Chavoshi

Iran University of Medical Sciences

Chavoshi.t@iums.ac.ir+98 21 2304 6253

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026